Hi everyone,
First time contributor.
I came on board with RAC shares in October 2018. Saw some promise with the likelihood of an expedited IND application, and the short-timeframe needed to fulfil the childhood case study for bisantrene.
I know the SP has been driven down due to a lack of financially positive news. One thing I would like is more consistent news from RAC surrounding the IND application. I feel the greatest value driver will be the potential for a saleable review. But it doesn't feel like we are getting enough of an update along the way. Q1 2019 for IND is vague. I'd like to hear more specifics. Surely that would stabilise the SP to keep us as shareholders feeling a little more comfortable.
2019 SP
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.85 |
Change
-0.005(0.27%) |
Mkt cap ! $315.1M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.86 | $1.85 | $26.00K | 14.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $1.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.89 | 500 | 1 |
View Market Depth
| Last trade - 10.08am 17/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |